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Background: Restenosis following nitinol stent implantation in the superficial femoral artery (SFA) predominantly occurs within a year. However, 
factors associated with the restenosis have not been systematically studied. We sought to investigate the restenosis factors within a year following 
the nitinol stent implantation in the SFA.
Methods: This study was a multicenter, retrospective analysis for the prospective maintained database from April 2004 to December 2008. 
We studied 639 limbs in consecutive 510 patients with peripheral artery disease (age, 71±9 years; female, 28%; critical limb ischemia, 23%) 
who underwent successful endovascular therapy with nitinol stents in the SFA. Restenosis was detected by duplex ultrasound. Stent fracture was 
identified by X-ray. Single regression and subsequent multivariate analyses were performed to explore the independent determinants of restenosis 
occurred within a year.
Results: Average lesion length was 147±91 mm, and 45% lesions was TASC C/D. Primary patency was 80, 67, 63% at 1, 3, 5 years, respectively. 
Stent fracture was observed in 14% lesions. A multiple logistic analysis showed stent fracture, TASC C/D lesion and administration of cilostazol were 
the strong independent factors associated with the restenosis occurring within a year .
Conclusion: Stent fracture and TASC II CD lesion were associated with restenosis, and cilostrazol was negatively associated with restenosis 
occurring within a year following nitinol stent implantation in the SFA.
